Related Experiment Video
Updated: Sep 6, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.0K
Pharmacist-Managed Diabetes Programs: Improving Treatment Adherence and Patient Outcomes
Amanda Wojtusik Orabone1, Vincent Do1, Elizabeth Cohen2
1Department of Pharmacy, Yale New Haven Health System, New Haven, CT, USA.
Summary
Pharmacists play a vital role in diabetes mellitus management, improving patient outcomes and reducing healthcare costs. This review highlights their impact in various care models and future opportunities for pharmacist-led diabetes care.
Area of Science:
- Pharmacology and Pharmaceutical Sciences
- Endocrinology
- Public Health
Background:
- Diabetes mellitus presents a significant global health and economic challenge.
- Effective management is crucial for preventing complications and reducing healthcare expenditures.
- Pharmacists are uniquely positioned to provide essential diabetes care within communities.
Purpose of the Study:
- To conduct a narrative review of the literature on pharmacist involvement in diabetes care.
- To explore the role of pharmacists in various diabetes management models.
- To examine outcomes associated with pharmacist-provided diabetes care and identify future opportunities.
Main Methods:
- A comprehensive literature search was performed.
- Studies examining pharmacist interventions in diabetes care were reviewed.
- Data on clinical and non-clinical outcomes were synthesized.
Main Results:
- Pharmacist-led interventions demonstrate clear benefits in improving patient outcomes.
- Pharmacists contribute to managing macrovascular and microvascular complications.
- Their involvement can lead to reduced healthcare costs.
Conclusions:
- Pharmacists are integral to effective diabetes mellitus management.
- Expanding pharmacist-managed diabetes care models offers significant potential.
- Future research should focus on optimizing pharmacist roles in diabetes care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
353
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
353
01:28Drug Therapy
96
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
96
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:16Insulin: Dosing Regimen and Adverse Effects
249
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
249
01:23Dipeptidyl Peptidase 4 Inhibitors
248
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
248
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K